Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sally A. Breisch"'
Publikováno v:
Clinical Therapeutics. 19:975-988
The efficacy and safety of grepafloxacin in treating patients with community-acquired pneumonia (CAP) was assessed in an open-label, noncomparative study. Patients (N = 273) received grepafloxacin 600 mg QD for 10 days. A total of 237 patients (87%)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3517c6015bed0e22b70d693e56090acb
https://doi.org/10.1016/s0149-2918(97)80050-1
https://doi.org/10.1016/s0149-2918(97)80050-1
Autor:
Jose Flores Figueroa, Jaime Belkind-Gerson, David Flyer, Pablo C. Okhuysen, Sally A. Breisch, Raniya N. Kassem, Olga Torres, Francisco G. Martinez-Sandoval, Juan Hm Meléndez-Romero, Gregory M. Glenn, Kazem Kazempour, Bo H. Andersen, Robin McKenzie, Ana S. Hoffman, Jane Halpern, A. Louis Bourgeois, Zhi-Dong Jiang, Sarah A. Frech, Norma H. Guerrero, Christina P. Villar, Edwin J. Asturias, Herbert L. DuPont
Publikováno v:
Lancet (London, England). 371(9629)
Summary Background Enterotoxigenic Escherichia coli (ETEC) is a major cause of travellers' diarrhoea. We investigated the rate of diarrhoea attacks, safety, and feasibility of a vaccine containing heat-labile enterotoxin (LT) from ETEC delivered to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b3f46e7c20bb8db1121fbce257c8a9
https://pubmed.ncbi.nlm.nih.gov/20065919
https://pubmed.ncbi.nlm.nih.gov/20065919